Dataset Information


Efficacy of reduced-dose regimen of a capsule containing bismuth subcitrate, metronidazole, and tetracycline given with amoxicillin and esomeprazole in the treatment of Helicobacter Pylori infection.

ABSTRACT: It is well known that triple therapy for Helicobacter pylori is losing efficacy worldwide. A regimen containing proton pump inhibitor and multiple-dose capsules of bismuth, metronidazole, and tetracycline has proven efficacy. In addition, a literature review on dosage of previous regimens shows that half-dose clarithromycin-based regimens are equally effective to full-dose regimens. However, the applicability of dose reduction to bismuth-based therapy is unknown. This communication shows that a reduced-dose bismuth-based regimen fails to achieve acceptable eradication rates.


PROVIDER: S-EPMC4315687 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC5995362 | BioStudies
2020-01-01 | S-EPMC7383804 | BioStudies
1997-01-01 | S-EPMC1891448 | BioStudies
2016-01-01 | S-EPMC4962407 | BioStudies
2020-01-01 | S-EPMC7559363 | BioStudies
2017-01-01 | S-EPMC5534286 | BioStudies
2018-01-01 | S-EPMC6257664 | BioStudies
2011-10-01 | E-MTAB-787 | ArrayExpress
2020-01-01 | S-EPMC7412782 | BioStudies
2005-01-01 | S-EPMC546758 | BioStudies